Search results (28)
Page
Article
Specialty Drug Fraud, Waste and Abuse Prevention
By leveraging automation as the linchpin of a comprehensive plan to mitigate fraud, waste and abuse, plan sponsors can help drive significantly lower specialty drug spending.
Read More
Article
Easing the impact of GLP-1s
With GLP-1 sales forecast to exceed $100 billion, plan sponsors need the tools to control growth and expand access.
Read More
Article
Two Ways to Assess the Holistic Value of Your Specialty Partner
Getting the most value out of your specialty drug management partner starts with asking the right questions.
Read More
Page
Article
With the right formulary, plans can control drug costs while preserving access
Each plan determines which formulary is best for its unique circumstances.
Read More
Page
Page
expert
expert